News
Big Data 4 Better Outcomes: Recommendations for the European Health Data Space 16 Jul 2021

In light of our experience in various projects of the Innovative Medicines Initiative’s Big Data 4 Better Outcomes programme (IMI BD4BOs), we would like to highlight the following points and make recommendations to inform EU decision makers in order to respond to the public consultation on the European Health Data Space (EHDS).

You can download the .pdf with the recommendations via this link: https://www.roadmap-alzheimer.org/wp-content/uploads/2021/07/BD4BOs-recommendations_on_EHDS_final_version_IMI.pdf

More News
New publication: Health economic modeling for Alzheimer's disease: Expert perspectives New publication: Health economic modeling for Alzheimer's disease: Expert perspectives 16 Nov 2022 The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers....
The Neuronet Coordination and Support Action releases updated Decision Tool for engagement with Regulatory and Health Technology Assessment bodies The Neuronet Coordination and Support Action releases updated Decision Tool for engagement with Regulatory and Health Technology Assessment bodies 09 May 2022 Madrid, 9 May 2022 – Today, the members of the New publication: Conducting public involvement in dementia research: The contribution of the European Working Group of People with Dementia to the ROADMAP project New publication: Conducting public involvement in dementia research: The contribution of the European Working Group of People with Dementia to the ROADMAP project 06 Apr 2021 Dementia outcomes include memory loss, language impairment, reduced quality of life and personality changes. Research suggests that outcomes selected for dementia clinical trials might not be the most important to people affected....